HSG

New Vision Medical is an IT infrastructure service provider that offers clinical trial-related digital platforms and services.

The Whole Truth specializes in the production of protein bars that emphasize health and nutrition. The company focuses on creating snacks that are free from added sugars, artificial sweeteners, preservatives, and flavoring agents. Utilizing natural ingredients such as dry fruits, cocoa, and raw whey, The Whole Truth aims to offer a nutritionally balanced option for consumers seeking wholesome snacks. Their products can be conveniently purchased online, allowing customers across India to enjoy minimally processed and nutritious snacks delivered directly to their homes.

Meichuang Medical is an innovative medical device company that focuses on the R&D, manufacturing and commercialization of high-end medical devices in the fields of peripheral vascular intervention, tumor intervention, and hemodialysis access maintenance

Normunity is a biotechnology company focused on developing precision immuno-oncology medicines, specifically a new class known as immune normalizers. These medicines aim to target novel mechanisms that enhance the body’s natural immune response against cancer. In collaboration with the lab of Dr. Lieping Chen at Yale School of Medicine, Normunity is researching newly-discovered mechanisms of immune disruption in cancer, utilizing proprietary discovery platforms to explore the intricate interactions between cancer and the immune system. The company is advancing a pipeline of immune normalizers, which includes initial drug programs designed to address the exclusion of T-cells from immune-sensitive tumors and other factors that impede normal immune function in cancer. Normunity operates from locations in Boston, Massachusetts, and West Haven, Connecticut.

Smiles.ai leverages proprietary technology and expert healthcare professionals to provide access to high-quality and cost-effective dental care products and services.

Cloudphysician is a prominent provider of Smart-ICU services, utilizing a cloud-based platform to enhance critical care delivery. The company employs advanced technologies such as artificial intelligence, the Internet of Things, and predictive analytics to facilitate real-time clinical decision-making. This innovative approach supports early-stage diagnosis of critical diseases in adults and monitors immunization schedules and growth profiles of newborns, aimed at reducing neonatal mortality rates. By combining medical expertise with technology, Cloudphysician improves patient outcomes and offers hospitals and healthcare providers enhanced monitoring, support, and training, ultimately transforming the landscape of critical care in the healthcare industry.

Taiyi Guanjia is a company that combines technology and medical health innovation, aiming to enhance the insurance industry and create a robust medical and health ecosystem.

Full-Life Technologies is a radiotherapeutics company focused on the research, development, production, and commercialization of radiopharmaceuticals aimed at cancer therapy. The company specializes in targeted cancer treatment, leveraging advancements in nuclear medicine to enhance clinical outcomes for patients. By prioritizing innovative radiopharmaceutical research, Full-Life Technologies aims to improve treatment results for those affected by cancer, demonstrating a commitment to delivering significant clinical impact in the field of oncology.

Twin Health, Inc. is a precision health company focused on reversing diabetes and chronic diseases through its innovative health platform. Founded in 2018 and based in Mountain View, California, with additional offices in India, Twin Health utilizes artificial intelligence and Internet-of-Things technologies to accurately measure and address metabolic health issues, which are often the underlying causes of chronic conditions. The platform incorporates sensors and advanced machine learning to analyze biosignals from wearables, predict metabolic outcomes, and provide personalized treatment recommendations tailored to each patient's metabolic profile. The company has secured significant funding from prominent venture capital firms and holds multiple patents related to its technology, positioning it as a leader in the field of metabolic health.

FUE Bioscience is a medical robot R&D business that specializes in microsurgery above the head and neck. It continues to develop a product matrix of fully intelligent, high-precision, and anthropomorphic surgical robots based on the platform of macro-micro-controlled humanoid dual-arm robots.

Yangqi Intelligent provides answers for medical equipment. It provides goods like qise, elixir, wonder vision, odd control, and more. A self-made radiation body surface monitoring camera is called wonder vision. Qice is a platform for artificial intelligence-based medical models. Sales.

Neurowyzr specializes in brain healthcare by offering a platform that focuses on the detection, diagnosis, therapy, monitoring, and prevention of cognitive decline. The company's innovative approach provides healthcare providers with evidence-based tools aimed at enhancing awareness of brain health. By facilitating early intervention and promoting preventive measures, Neurowyzr seeks to transform societal attitudes towards brain health, ultimately enabling individuals to manage and maintain their cognitive well-being effectively.

Neurophth is China's first gene therapy company for ophthalmic diseases. As a clinical-stage company, Neurophth is dedicated to discovering and developing gene therapies for patients suffering from blindness and other eye diseases globally.

Meichuang Medical is an innovative medical device company that focuses on the R&D, manufacturing and commercialization of high-end medical devices in the fields of peripheral vascular intervention, tumor intervention, and hemodialysis access maintenance

Huayuan Regenerative Medicine is the manufacture of implantable bioartificial organs. Huayuan Regenerative Medicine is committed to the research and development, production, and sales of clinical grade stem cells, biological tissue engineering products, and biomanufacturing. Their clinical products include urinary kidney precursor cells, dialysis equipment, and a biosynthetic artificial pancreas.

The Whole Truth specializes in the production of protein bars that emphasize health and nutrition. The company focuses on creating snacks that are free from added sugars, artificial sweeteners, preservatives, and flavoring agents. Utilizing natural ingredients such as dry fruits, cocoa, and raw whey, The Whole Truth aims to offer a nutritionally balanced option for consumers seeking wholesome snacks. Their products can be conveniently purchased online, allowing customers across India to enjoy minimally processed and nutritious snacks delivered directly to their homes.

Yangqi Intelligent provides answers for medical equipment. It provides goods like qise, elixir, wonder vision, odd control, and more. A self-made radiation body surface monitoring camera is called wonder vision. Qice is a platform for artificial intelligence-based medical models. Sales.

RedBrick AI is a software-as-a-service platform focused on annotating medical data, particularly in the field of radiology. It offers specialized web-based annotation tools for both 2D and 3D medical imagery, which can be seamlessly integrated into existing data storage systems used by healthcare providers. The platform is designed to streamline the annotation process by allowing clinicians to access robust tools directly through their browsers. Additionally, it features functionalities such as workflow control, user management, task assignment, and custom validation checks. These capabilities enable hospitals and medical associations to efficiently manage annotations and facilitate their integration with machine learning operations, ultimately supporting the development of healthcare artificial intelligence.

Insight Lifetech is a medical technology company focused on creating innovative solutions for the diagnosis and treatment of cardiovascular diseases. It has developed a synergistic platform that integrates research and development, manufacturing, and commercialization, which enhances collaboration, accelerates product development, and promotes cost efficiency. The company is notable for creating the first and only domestic fractional flow reserve (FFR) system in China that has received approval from the National Medical Products Administration (NMPA). By manufacturing high-quality medical devices that feature reliable precision diagnostics and therapeutic capabilities, Insight Lifetech aims to empower physicians to improve patient outcomes and save lives.

Founded in 2012, Vivolight is a medical device company incubated and supported by Xi'an Institute of Optics and Precision Mechanics of Chinese Academy of Sciences. We are headquartered in Shenzhen and have established an R&D center in Xi’an. Rooted in the field of medical laser technology, we are committed to the independent development, global innovation and independent manufacturing of medical devices used for minimally invasive interventional diagnosis and treatment with the technology of laser by leveraging the world-leading photoelectric technology and combining medicine and engineering. In April 2020, our self-developed optical coherence tomography (OCT) system obtained the approval of NMPA and achieved commercialization. In December 2021, our innovative Multimodality OCT System was approved by NMPA. It is the first Multimodality OCT System in the field of coronary artery OCT that has been approved for clinical application. In the field of interventional laser therapy, we have multiple products that have entered the phase of pre-clinical study.

WuXi Bo Rui Biotechnology develops a radioactive molecular imaging and nuclear drug transformation platform for the precise diagnosis and treatment of tumors. WuXi Bo Rui Biotechnology focuses on the transformation and development of new radionuclide drugs, covering multiple fields of small molecules, peptides, and antibodies, for the diagnosis and treatment of tumors, using their professional platform for targeted precursor design, screening, and radionuclide labeling. While increasing the efficiency of research and development, it also fully utilizes the benefits of accurate nuclear medicine diagnosis and treatment

Spectrum Medical is a clinical mass spectrometry product platform that promotes clinical mass spectrometry detection technology to the general public. It has an experienced research and development, operations, and sales team, a standardized GMP production workshop, extensive experience in laboratory construction, and a mature laboratory management system. It provides with complete supporting kits in addition to mastering the core mass spectrometry hardware manufacturing technology and equipment integration development capabilities (maternal and child genetics, nutritional levels, therapeutic drug testing, metabolic monitoring, etc.).

DigitAlp is a scientific and technical innovation company focused on enhancing the value of clinical research through a comprehensive digital solution tailored for institutions. The company offers an integrated platform consisting of four key modules: an institutional comprehensive management system, a trial electronic medical record system designed for research wards, a sponsor service system, and a subject recruitment and full-service system. This suite of tools enables various stakeholders in clinical research to manage their operations more efficiently, ultimately streamlining the entire clinical trial process.

Full-Life Technologies is a radiotherapeutics company focused on the research, development, production, and commercialization of radiopharmaceuticals aimed at cancer therapy. The company specializes in targeted cancer treatment, leveraging advancements in nuclear medicine to enhance clinical outcomes for patients. By prioritizing innovative radiopharmaceutical research, Full-Life Technologies aims to improve treatment results for those affected by cancer, demonstrating a commitment to delivering significant clinical impact in the field of oncology.

Scientech Medical engages in the research, development, and manufacturing of interventional medical devices.

Xmov is a company that specializes in developing artificial reality animation solutions, focusing on virtual human and content creation tailored for enterprise users across various Metaverse applications. The company employs advanced motion capture, animation, and artificial intelligence technologies to deliver customized interactive solutions for diverse business scenarios. Additionally, Xmov creates a comprehensive infrastructure for 3D virtual content production, providing full-stack technology and product services aimed at facilitating education, employment, and the development of virtual world platforms. Their innovative approach spans multiple sectors, including entertainment, cultural tourism, e-commerce, finance, education, healthcare, and communications, establishing a multifaceted ecological development model.

Xmov is a company that specializes in developing artificial reality animation solutions, focusing on virtual human and content creation tailored for enterprise users across various Metaverse applications. The company employs advanced motion capture, animation, and artificial intelligence technologies to deliver customized interactive solutions for diverse business scenarios. Additionally, Xmov creates a comprehensive infrastructure for 3D virtual content production, providing full-stack technology and product services aimed at facilitating education, employment, and the development of virtual world platforms. Their innovative approach spans multiple sectors, including entertainment, cultural tourism, e-commerce, finance, education, healthcare, and communications, establishing a multifaceted ecological development model.

XISOFT is a professional manufacturer specializing in informatization and data services within health economic management. The company develops an enterprise resource planning (ERP) platform tailored for hospitals, providing comprehensive management and monitoring capabilities across various functions, including finance, supply chain, human resources, and diagnosis-related groups. By leveraging technology, XISOFT aims to support medical institutions in streamlining operations and enhancing efficiency. Its platform enables effective business integration and refined management, addressing key areas such as intelligent finance, material assets, internal control, and event management. Through its innovative solutions, XISOFT assists healthcare providers in realizing their strategic objectives and improving overall operational effectiveness.

Grit Science is a biotechnology company specializing in gene therapeutics, particularly focusing on the research and development of liver-related genes. The firm is dedicated to creating medical products and genetic treatments that address clinical needs and enhance human health. Through its innovative approach to biopharmaceutical technology, Grit Science aims to contribute significantly to the field of medicine by developing solutions that improve patient outcomes.

Xueji Bio is a new cell therapy company founded by returnee experts to regenerate hematopoietic lineages (including blood cells and immune cells) in vitro, with unique stem cell reprogramming, editing and differentiation technologies. The company's unique iPSC establishment technology and gene targeting technology can quickly establish a platform using platelet cells as a drug delivery carrier.

Sirka is Indonesia's pioneering metabolic clinic, focused on healthcare innovation through a technology-enabled, holistic approach to managing obesity and metabolic health. The clinic addresses the root causes of weight gain and chronic diseases, offering services that include weight management, digestive health, diabetes care, and chronic disease management. Sirka provides personalized, clinically proven programs tailored to individual needs, combining expert medical care with customized nutrition plans and continuous monitoring. Clients can connect with dietitians through an application, allowing them to set health goals and receive meal plan recommendations as part of structured programs. Sirka aims to empower Indonesians to lead healthier lives by improving weight management and enhancing control over chronic conditions.

the first high-tech company in China to focus on the treatment of cerebrovascular disease, it has more than four years of product research and development, leading China's cerebrovascular disease intelligence in an all-around way. vertical field of diagnosis and treatment. It has become a well-known brain stroke intelligence diagnosis and treatment platform in China.

Tongxin makes magnetically-suspended artificial blood pumps which are designed to replace the human heart. They are undergoing clinical trials in China after being fast-tracked through the approval process by the National Medical Products Administration, state-run Xinhua News Agency

Smiles.ai leverages proprietary technology and expert healthcare professionals to provide access to high-quality and cost-effective dental care products and services.

Vibrant develops an AI drug development platform to focus on building immune system-related drug pipelines. The company will use artificial intelligence algorithms to accelerate the efficiency of drug development in various aspects such as target discovery, drug design, and drug efficacy evaluation; at the same time, the company expects to continuously improve the success rate of drug development through sustainable data accumulation and algorithm optimization. It was founded and headed by Dr. Wang Luquan and is based in Guangzhou, Guangdong, China.

Atom Bioscience is a clinical-stage biotechnology company focused on developing innovative therapies for inflammatory and metabolic diseases. The company concentrates on addressing conditions such as chronic gout, non-alcoholic steatohepatitis, diabetes, and colon cancers. By targeting the underlying mechanisms of metabolism and inflammation, Atom Bioscience aims to provide patients with more effective treatment options for these complex health issues.

Dangsheng New Material is a high-performance fiber material developer and a high-tech enterprise dedicated to the development, production and sales of high-performance fiber materials. It has realized the production of China's only high-performance anti-virus and biochemical barrier protective clothing made of a single material. . Dangsheng New Materials provides a series of medical disposable protective products, including protective clothing, isolation clothing, protective shoe covers and other supplies.

ABclonal Inc. is a life science research and diagnostic reagents provider based in Woburn, Massachusetts, established in 2016. The company specializes in offering a range of biological research agents and services, including next generation sequencing library preparation kits, molecular biology products, catalog antibodies, catalog proteins, ELISA kits, and tools for western blotting. Additionally, ABclonal provides peptide, antibody, and protein services. The company distributes its products through a network that spans Europe, Asia, North America, and Oceania. With a team of scientists from leading universities, ABclonal is committed to enhancing the quality of life science research through its high-quality offerings.

Pristyn Care is a Health Care Startup that is disrupting Day Care Procedures. It is founded by Ex Consultant Surgeons from Medanta, Max, Birla and ex UrbanClap, Mobikwik Strategy & Business Head. Pristyn Care's team is young and passionate, and we see massive opportunity in the healthcare industry. By leveraging technology, and a set of simple yet powerful processes and operations, we wish to build an ecosystem which can organize the world of day care procedures. We are leveraging some of the most advanced tech developments in the field of healthcare for this goal.

SyMap Medical focuses on developing and manufacturing a proprietary catheter-based system for renal mapping and ablation, specifically aimed at treating hypertension and various other serious conditions, including heart failure, arrhythmia, and renal failure. The company's core technology platform is based on radiofrequency (RF) ablation, which is integral to its approach in renal nerve mapping and selective ablation. This innovative medical device is designed to enhance treatment options for patients suffering from these significant health issues.

Neurophth is China's first gene therapy company for ophthalmic diseases. As a clinical-stage company, Neurophth is dedicated to discovering and developing gene therapies for patients suffering from blindness and other eye diseases globally.

KingstronBio manufactures artificial heart valves and annuloplasty rings.

Jianhai Technology is an AI whole-course management platform that provides users with post-hospital & post-diagnosis management services.

Suzhou Xinqing Medical Technology Co., Ltd., founded in 2017 by Dr. Xu Bozhen, focuses on the development of in-vitro artificial heart devices aimed at assisting patients with cardiovascular illnesses. The company specializes in creating short-term to medium-term ventricular assist devices that leverage advanced fluid mechanics and magnetic suspension technology. These innovations allow the devices to be compatible with various blood types, thereby reducing the risk of incompatibility for patients. With a team of leading experts in artificial heart engineering, the company has successfully developed an artificial heart that holds independent intellectual property rights, positioning itself as a key player in the medical technology sector.

Twin Health, Inc. is a precision health company focused on reversing diabetes and chronic diseases through its innovative health platform. Founded in 2018 and based in Mountain View, California, with additional offices in India, Twin Health utilizes artificial intelligence and Internet-of-Things technologies to accurately measure and address metabolic health issues, which are often the underlying causes of chronic conditions. The platform incorporates sensors and advanced machine learning to analyze biosignals from wearables, predict metabolic outcomes, and provide personalized treatment recommendations tailored to each patient's metabolic profile. The company has secured significant funding from prominent venture capital firms and holds multiple patents related to its technology, positioning it as a leader in the field of metabolic health.

Vision X is a solutions provider for medical equipment in the field of ophthalmology and optometry.

MetWare is a developer of advanced metabolic technology that focuses on metabolism analysis and testing services for various health conditions, including cancer, metabolic disorders, and infectious diseases. The company utilizes innovative metabolomics technology to enhance life science research and medical applications. By providing clinical testing products and data analysis, MetWare aims to support healthcare professionals in delivering effective treatment to patients. Their commitment to applying cutting-edge technology in the medical field positions them as a significant contributor to improving health outcomes through detailed metabolic insights.

Yixue Jie is an app that offers medical information to medical workers. They provide information in these categories such as grassroots medical voice in the medical field, medical tumor channel, medical rheumatology and immunity channel, medical skin channel, medical cardiovascular channel, medical endocrinology channel, medical neurology channel, medical blood channel, medical pediatric channel, medical obstetrics and gynecology channel, medical respiratory channel, medical nephrology channel, digestive liver disease channel in medical circles, clinical pharmacy channel of the medical community, medical rare disease channel, medical cancer association, medical emergency and critical care channel, medical spirit channel, medical surgical channel, medical nursing channel, medical ophthalmology channel, medical infection channel, medical anesthesia channel, medical orthopedics channel, medical testing channel, medical image diagnosis and intervention channel, medical pathology channel, clinical decision assistant, a course in the medical field, and medical examination. It helps clinicians in clinical decision-making and professional advancement.

XtalPi Inc. is a pharmaceutical technology company based in Cambridge, Massachusetts, with additional offices in China. Founded in 2014 by a team of quantum physicists from MIT, XtalPi focuses on transforming drug research and development through its Intelligent Digital Drug Discovery and Development (ID4) platform. This platform integrates quantum mechanics, artificial intelligence, and high-performance cloud computing to enhance the efficiency and accuracy of drug R&D processes. XtalPi's offerings include advanced tools for crystal structure prediction and determination, solid state testing, small molecule drug design, and AI model development. The company aims to accelerate drug discovery and development, thereby contributing to global health improvements. Its innovative technologies have garnered recognition within the industry and facilitated strategic partnerships with leading pharmaceutical companies.

Miaoshou Doctor is a healthcare service platform for building an online communication service platform between patients and doctors. It helps healthcare professionals and patients to manage post-diagnosis outcomes and allows doctors to actively follow up with their patient's health through additional counseling and prescriptions. Tao He and Daoliang Han founded the company in 2015 and is based in Beijing, Beijing.

Yuanxin Huibao is a health insurance technology service provider that specializes in medical insurance, particularly for major and chronic diseases. The company offers a comprehensive suite of services that includes special drug services, video consultations, welfare drugs, and claims investigations. By integrating these features, Yuanxin Huibao aims to deliver reliable medical services and improve insurance coverage for its users. Additionally, the company provides insurance firms with a one-stop solution for risk control and actuarial pricing, enhancing the overall efficiency and effectiveness of the health insurance process.

Shanghai Anovent Pharmaceutical Co., Ltd., founded in 2017 and headquartered in Shanghai, China, specializes in the development of high-quality inhalation medicines tailored for hospitals and medical institutions. The company focuses on offering safe and affordable pharmaceutical products, which include both generic and specialized inhalation therapies. By providing these medications, Anovent aims to enhance the quality of medical treatment available to patients in healthcare settings.

Joyo Pharma focuses on the research and development of drugs for the treatment of tumors, autoimmunity, metabolism, and infectious diseases.

The Whole Truth specializes in the production of protein bars that emphasize health and nutrition. The company focuses on creating snacks that are free from added sugars, artificial sweeteners, preservatives, and flavoring agents. Utilizing natural ingredients such as dry fruits, cocoa, and raw whey, The Whole Truth aims to offer a nutritionally balanced option for consumers seeking wholesome snacks. Their products can be conveniently purchased online, allowing customers across India to enjoy minimally processed and nutritious snacks delivered directly to their homes.

Westlake Therapeutics is a biopharmaceutical company based in Hangzhou, China, founded in 2019. The company specializes in cell therapy, focusing on developing innovative treatments for rare diseases, cancer, and various immunological and metabolic disorders. Central to its approach is the REDx platform, which utilizes engineered red blood cell technology. This platform enables the genetic engineering of hematopoietic stem and progenitor cells sourced from peripheral blood, bone marrow, or cord blood. By leveraging this technology, Westlake Therapeutics aims to create personalized therapies that enhance treatment options for patients facing a wide range of health challenges.

Huayuan Regenerative Medicine is the manufacture of implantable bioartificial organs. Huayuan Regenerative Medicine is committed to the research and development, production, and sales of clinical grade stem cells, biological tissue engineering products, and biomanufacturing. Their clinical products include urinary kidney precursor cells, dialysis equipment, and a biosynthetic artificial pancreas.

HiFiBiO is a biotherapeutics company that mobilizes the human immune system to combat disease. It commercializes proprietary single-cell technologies for applications in drug and biomarker discovery and development. It also aspires to benefit patients through open-innovation partnerships with industry and academia. HiFiBiO integrates deep-rooted biological expertise with its comprehensive single-cell profiling technologies to discover and accelerate a pipeline of antibody drugs to treat cancer and autoimmune disorders. The company was founded in 2013 and is headquartered in Paris, Ille-de-France.

Stemirna Therapeutics is a RNA technology based drug development company designed to maximize the potential of RNA science. The company currently has more than a dozen of independently-developed mRNA drug projects, focusing on the fields of mRNA-based personalized cancer vaccines, mRNA vaccines for infectious disease, protein defects diseases, and genetic diseases, providing cure and solutions for cancer and infectious diseases, better serving patients.

Zenyum is a Singaporean start-up established in 2018 that focuses on enhancing dental experiences through technology and innovation. The company aims to improve smiles across Asia by offering high-quality dental products, including 3D-printed invisible braces. Zenyum collaborates with a network of professional dentists to provide customers with safe, effective, and affordable clear teeth aligning devices. By transforming traditional dental routines into engaging experiences, Zenyum is committed to making dental care accessible and enjoyable for everyone.

XISOFT is a professional manufacturer specializing in informatization and data services within health economic management. The company develops an enterprise resource planning (ERP) platform tailored for hospitals, providing comprehensive management and monitoring capabilities across various functions, including finance, supply chain, human resources, and diagnosis-related groups. By leveraging technology, XISOFT aims to support medical institutions in streamlining operations and enhancing efficiency. Its platform enables effective business integration and refined management, addressing key areas such as intelligent finance, material assets, internal control, and event management. Through its innovative solutions, XISOFT assists healthcare providers in realizing their strategic objectives and improving overall operational effectiveness.

Phanes Therapeutics, Inc. is a biotechnology company based in San Diego, California, established in 2016. The company specializes in drug discovery and early development, primarily in the fields of immuno-oncology and eye diseases. Phanes Therapeutics is developing a range of therapeutic molecules, including a monoclonal antibody aimed at treating solid tumors, as well as therapies for age-related macular degeneration, diabetic macular edema, and diabetic retinopathy. Additionally, the company is working on bispecific antibodies targeting small cell lung cancer. Through its extensive scientific expertise and innovative approaches, Phanes Therapeutics aims to create effective treatment options that enhance patient care and improve outcomes for those suffering from various conditions.

Valgen focus on treatment technologies and systemic solutions for heart disease, especially for mitral and tricuspid valve lesions.

EdiGene Inc. is a biotechnology company based in Beijing, China, with additional offices in Guangzhou and Cambridge, Massachusetts. Founded in 2015, EdiGene specializes in the development of advanced genome editing technologies aimed at addressing various genetic diseases and cancer. The company focuses on both ex vivo and in vivo gene-editing therapies, utilizing proprietary platforms for modifying genetic information in human cells. Their innovative approaches include gene knockout, knock-in, and targeted mutations, which facilitate the creation of safer and more effective gene therapies. EdiGene also supports pharmaceutical research by providing high-throughput genome screening and drug target analysis, enhancing drug discovery efforts in the industry. Through its commitment to translating genome editing into therapeutics, EdiGene aims to improve human health outcomes and advance scientific research.

Pristyn Care is a Health Care Startup that is disrupting Day Care Procedures. It is founded by Ex Consultant Surgeons from Medanta, Max, Birla and ex UrbanClap, Mobikwik Strategy & Business Head. Pristyn Care's team is young and passionate, and we see massive opportunity in the healthcare industry. By leveraging technology, and a set of simple yet powerful processes and operations, we wish to build an ecosystem which can organize the world of day care procedures. We are leveraging some of the most advanced tech developments in the field of healthcare for this goal.

PackGene Biotech, LLC is a biotechnology company based in the United States that specializes in developing viral vectors for gene therapies. It primarily focuses on adeno-associated virus (AAV) vectors, offering comprehensive services that include vector design, cloning, and packaging. The company also provides solutions for mRNA, plasmid DNA, and lentiviral vectors. With an emphasis on early-stage drug discovery and preclinical development, PackGene Biotech supports researchers in the medical industry by delivering high-purity, high-titer, and high-infectivity vectors for clinical applications. Its capabilities enable scalable and cost-effective production, facilitating advancements in cell and gene therapy trials.

Connect Medical Value is a company based in Hangzhou, Zhejiang, China, that specializes in developing mobile applications for physicians. Founded in 2020, the company focuses on providing a comprehensive platform that integrates clinical services, scientific research, and educational resources. By leveraging advanced artificial intelligence technology, Connect Medical Value aims to enhance the capabilities of healthcare professionals, facilitating improved patient care and medical practice.

Qihan Biotech is a biomedical company based on genetic technology. Kaixin Bio ’s mission is to create a new world where patients do n’t have to wait for organ transplants. We are committed to using the world's advanced gene editing technology to produce safe and effective cells, tissues and organs that can be used for human transplantation, and to solve the serious shortage of organ transplant donors in China and the world.

Jianhai Technology is an AI whole-course management platform that provides users with post-hospital & post-diagnosis management services.

ABclonal Inc. is a life science research and diagnostic reagents provider based in Woburn, Massachusetts, established in 2016. The company specializes in offering a range of biological research agents and services, including next generation sequencing library preparation kits, molecular biology products, catalog antibodies, catalog proteins, ELISA kits, and tools for western blotting. Additionally, ABclonal provides peptide, antibody, and protein services. The company distributes its products through a network that spans Europe, Asia, North America, and Oceania. With a team of scientists from leading universities, ABclonal is committed to enhancing the quality of life science research through its high-quality offerings.

Neurophth is China's first gene therapy company for ophthalmic diseases. As a clinical-stage company, Neurophth is dedicated to discovering and developing gene therapies for patients suffering from blindness and other eye diseases globally.

Beijing Yuanxin is a technology company that offers an integrated healthcare platform for pharmaceutical distribution and health insurance.

Babycare is an e-commerce platform providing products for new parents and children. The company specializes in the design, research, and development of mother-baby products. Its products are based on recommendations by a series of research and experiments regarding orthopedic development of babies. One of its products is the infant waist carrier, which is crafted to improve the comfortability of infants and prevent from bowleg posturing which hinders blood circulation. The company is committed to achieving the aspiration of being product designers and baby caretakers. The company was founded in 2014 and is headquartered in Shanghai, China.

Smiles.ai leverages proprietary technology and expert healthcare professionals to provide access to high-quality and cost-effective dental care products and services.

Shanhu Health focuses on the development of clinical application software within the realm of digital medicine. The company creates computerized systems aimed at enhancing clinical research, including interactive response technology, electronic data capture, and clinical trial management systems, all utilizing cloud technology. Additionally, Shanhu Health offers consultancy services that support risk-based monitoring and the implementation of clinical trial systems, thereby facilitating more efficient drug development processes.

Insight Lifetech is a medical technology company focused on creating innovative solutions for the diagnosis and treatment of cardiovascular diseases. It has developed a synergistic platform that integrates research and development, manufacturing, and commercialization, which enhances collaboration, accelerates product development, and promotes cost efficiency. The company is notable for creating the first and only domestic fractional flow reserve (FFR) system in China that has received approval from the National Medical Products Administration (NMPA). By manufacturing high-quality medical devices that feature reliable precision diagnostics and therapeutic capabilities, Insight Lifetech aims to empower physicians to improve patient outcomes and save lives.

SciNeuro Pharmaceuticals is a biotechnology company based in Shanghai, China, focused on developing innovative medicines for patients with central nervous system (CNS) diseases. The company is committed to transforming the treatment landscape for these conditions through a robust product pipeline that emphasizes internal innovation and global collaboration. SciNeuro's drug development is guided by breakthrough scientific evidence, including insights from human genetics and pharmacology, targeting the underlying mechanisms of CNS diseases. By addressing these pathological mechanisms, SciNeuro aims to provide transformative therapies that not only aim to cure these diseases but also enhance the quality of life for patients.

PackGene Biotech, LLC is a biotechnology company based in the United States that specializes in developing viral vectors for gene therapies. It primarily focuses on adeno-associated virus (AAV) vectors, offering comprehensive services that include vector design, cloning, and packaging. The company also provides solutions for mRNA, plasmid DNA, and lentiviral vectors. With an emphasis on early-stage drug discovery and preclinical development, PackGene Biotech supports researchers in the medical industry by delivering high-purity, high-titer, and high-infectivity vectors for clinical applications. Its capabilities enable scalable and cost-effective production, facilitating advancements in cell and gene therapy trials.

EdiGene Inc. is a biotechnology company based in Beijing, China, with additional offices in Guangzhou and Cambridge, Massachusetts. Founded in 2015, EdiGene specializes in the development of advanced genome editing technologies aimed at addressing various genetic diseases and cancer. The company focuses on both ex vivo and in vivo gene-editing therapies, utilizing proprietary platforms for modifying genetic information in human cells. Their innovative approaches include gene knockout, knock-in, and targeted mutations, which facilitate the creation of safer and more effective gene therapies. EdiGene also supports pharmaceutical research by providing high-throughput genome screening and drug target analysis, enhancing drug discovery efforts in the industry. Through its commitment to translating genome editing into therapeutics, EdiGene aims to improve human health outcomes and advance scientific research.

XtalPi Inc. is a pharmaceutical technology company based in Cambridge, Massachusetts, with additional offices in China. Founded in 2014 by a team of quantum physicists from MIT, XtalPi focuses on transforming drug research and development through its Intelligent Digital Drug Discovery and Development (ID4) platform. This platform integrates quantum mechanics, artificial intelligence, and high-performance cloud computing to enhance the efficiency and accuracy of drug R&D processes. XtalPi's offerings include advanced tools for crystal structure prediction and determination, solid state testing, small molecule drug design, and AI model development. The company aims to accelerate drug discovery and development, thereby contributing to global health improvements. Its innovative technologies have garnered recognition within the industry and facilitated strategic partnerships with leading pharmaceutical companies.

Pristyn Care is a Health Care Startup that is disrupting Day Care Procedures. It is founded by Ex Consultant Surgeons from Medanta, Max, Birla and ex UrbanClap, Mobikwik Strategy & Business Head. Pristyn Care's team is young and passionate, and we see massive opportunity in the healthcare industry. By leveraging technology, and a set of simple yet powerful processes and operations, we wish to build an ecosystem which can organize the world of day care procedures. We are leveraging some of the most advanced tech developments in the field of healthcare for this goal.

AccuMedical is a full-line product company in the field of neurological intervention, headquartered in Beijing with an R&D center located in California. It develops and produces medical device products for the treatment of aneurysms, preventing, and treating bleeding diseases caused by the rupture of vascular aneurysms.

Miaoshou Doctor is a healthcare service platform for building an online communication service platform between patients and doctors. It helps healthcare professionals and patients to manage post-diagnosis outcomes and allows doctors to actively follow up with their patient's health through additional counseling and prescriptions. Tao He and Daoliang Han founded the company in 2015 and is based in Beijing, Beijing.

JW Therapeutics (Shanghai) Co., Ltd. is a biotechnology company based in Shanghai, China, that specializes in developing, manufacturing, and promoting cell-based immunotherapies aimed at treating cancer. The company leverages advanced technologies, including chimeric antigen receptor (CAR) and T cell receptor (TCR) therapies, to enhance the body's immune response against cancer. JW Therapeutics focuses on addressing both hematological cancers and solid tumors, with its leading product candidate being relmacabtagene autoleucel, designed as a potential superior anti-CD19 CAR-T therapy. The company's mission is to improve patient outcomes and quality of life for those battling cancer through innovative treatment solutions.

Beijing Yuanxin is a technology company that offers an integrated healthcare platform for pharmaceutical distribution and health insurance.

Atom Bioscience is a clinical-stage biotechnology company focused on developing innovative therapies for inflammatory and metabolic diseases. The company concentrates on addressing conditions such as chronic gout, non-alcoholic steatohepatitis, diabetes, and colon cancers. By targeting the underlying mechanisms of metabolism and inflammation, Atom Bioscience aims to provide patients with more effective treatment options for these complex health issues.

BuyMed operates an e-commerce website that connects pharmaceutical manufacturers, distributors, and clinics. Its platform, Thuocsi.vn, works on a variety of projects, including e-commerce, seller centers, supply portals, WMS, POS, and logistics services. It has been implementing the Circa pharmacy project, focusing more on patient customers.

Neurophth is China's first gene therapy company for ophthalmic diseases. As a clinical-stage company, Neurophth is dedicated to discovering and developing gene therapies for patients suffering from blindness and other eye diseases globally.

CERo Therapeutics, Inc. is a new cellular immunotherapy company. We have created a hybrid platform that integrates innate and adaptive programs to eliminate disease.

Nuanwa Technology is a health insurance technology platform that focuses on providing advanced solutions for the healthcare industry. The company serves insurance providers and internet platforms by offering product customization services, risk control, claims processing, and system integration. Utilizing cutting-edge technologies such as big data and artificial intelligence, Nuanwa Technology analyzes client medical data to assist in the selection and design of tailored healthcare plans. Additionally, the company aims to enhance medical ecology and health insurance by facilitating the sharing of medical data information, thereby breaking down existing barriers within the sector.

Qure AI is a healthtech startup that uses artificial intelligence assistance for medical imaging diagnostics. The company's mission is to make healthcare affordable and accessible using the power of artificial intelligence. They build deep learning solutions that aid physicians with routine diagnosis and treatment, allowing them to spend more time with patients. Qure AI was founded in 2016 and is based in Mumbai, Maharashtra.

Adagene is a clinical-stage biopharmaceutical company focused on developing innovative immuno-oncology antibodies targeting novel epitopes for cancer treatment. Utilizing its proprietary Smart Antibody Technology, Adagene aims to enhance the success rates of therapeutic antibodies while significantly accelerating the time to market and lowering development costs. The company is dedicated to the research, development, and production of monoclonal antibody drugs, with a pipeline that emphasizes creating therapeutic candidates characterized by functional epitopes and cross-reactivity across species. By transforming the discovery and development processes in the field of antibody-based cancer immunotherapies, Adagene is positioned to make a substantial impact on cancer treatment.

Transcenta is a global biotherapeutic company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacture, focusing on developing innovative antibodies to help more patients. HJB and MabSpace Biosciences merged and created Transcenta.

Eko Health is a leading digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes, patient and provider software, and AI-powered analysis. Its FDA-cleared platform is used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in Emeryville, California, with over $125 million in funding from Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, and others. For more information visit www.ekohealth.com.

Pristyn Care is a Health Care Startup that is disrupting Day Care Procedures. It is founded by Ex Consultant Surgeons from Medanta, Max, Birla and ex UrbanClap, Mobikwik Strategy & Business Head. Pristyn Care's team is young and passionate, and we see massive opportunity in the healthcare industry. By leveraging technology, and a set of simple yet powerful processes and operations, we wish to build an ecosystem which can organize the world of day care procedures. We are leveraging some of the most advanced tech developments in the field of healthcare for this goal.

ViGeneron is dedicated to developing innovative gene therapies to treat ophthalmic diseases with high unmet medical need, as well as partnering with leading biopharmaceutical players in other disease areas. The company’s pipeline is built on two proprietary adeno-associated virus (AAV) technology platforms. The first, vgAAV gene therapy vector platform, allows superior transduction efficiency and intravitreal, less invasive treatment administration. The second, REVeRT vector platform, targets diseases caused by mutations in large genes. Privately-owned ViGeneron was founded in 2017 by a seasoned team with in-depth experience in AAV vector technology and clinical ophthalmic gene therapy programs and is located in Munich, Germany.

Zenyum is a Singaporean start-up established in 2018 that focuses on enhancing dental experiences through technology and innovation. The company aims to improve smiles across Asia by offering high-quality dental products, including 3D-printed invisible braces. Zenyum collaborates with a network of professional dentists to provide customers with safe, effective, and affordable clear teeth aligning devices. By transforming traditional dental routines into engaging experiences, Zenyum is committed to making dental care accessible and enjoyable for everyone.

Shanghai Anovent Pharmaceutical Co., Ltd., founded in 2017 and headquartered in Shanghai, China, specializes in the development of high-quality inhalation medicines tailored for hospitals and medical institutions. The company focuses on offering safe and affordable pharmaceutical products, which include both generic and specialized inhalation therapies. By providing these medications, Anovent aims to enhance the quality of medical treatment available to patients in healthcare settings.

Qihan Biotech is a biomedical company based on genetic technology. Kaixin Bio ’s mission is to create a new world where patients do n’t have to wait for organ transplants. We are committed to using the world's advanced gene editing technology to produce safe and effective cells, tissues and organs that can be used for human transplantation, and to solve the serious shortage of organ transplant donors in China and the world.

Nuanwa Technology is a health insurance technology platform that focuses on providing advanced solutions for the healthcare industry. The company serves insurance providers and internet platforms by offering product customization services, risk control, claims processing, and system integration. Utilizing cutting-edge technologies such as big data and artificial intelligence, Nuanwa Technology analyzes client medical data to assist in the selection and design of tailored healthcare plans. Additionally, the company aims to enhance medical ecology and health insurance by facilitating the sharing of medical data information, thereby breaking down existing barriers within the sector.

HiFiBiO is a biotherapeutics company that mobilizes the human immune system to combat disease. It commercializes proprietary single-cell technologies for applications in drug and biomarker discovery and development. It also aspires to benefit patients through open-innovation partnerships with industry and academia. HiFiBiO integrates deep-rooted biological expertise with its comprehensive single-cell profiling technologies to discover and accelerate a pipeline of antibody drugs to treat cancer and autoimmune disorders. The company was founded in 2013 and is headquartered in Paris, Ille-de-France.